ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $2.07M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $2.57M, up 8,460.00% year-over-year. In the year 2023, ARS Pharmaceuticals had annual revenue of $30.00K, down -97.72%.

• Revenue (ttm): $2.57M
• Revenue Growth: +8,460.00%
• P/S Ratio: n/a
• Revenue / Employee: $98,769
• Employees: 26
• Market Cap: 1.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	30.00K	-1.29M	-97.72%
Dec 31, 2022	1.32M	-4.19M	-76.10%
Dec 31, 2021	5.51M	-12.33M	-69.13%
Dec 31, 2020	17.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.